[1] Martin A, David V, Quarles LD.Regulation and function of the FGF23/klotho endocrine pathways[J].Physiol Rev, 2012, 92(1):131-155.
[2] Penido MG, Alon US.Hypophosphatemic rickets due to perturbations in renal tubular function[J].Pediatr Nephrol, 2014, 29(3):361-373.
[3] Crowley RK, Kilbane M, King TF, et al.Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia:a case report[J].Journal of Medical Case Reports, 2014, 8(1):84-97.
[4] Sheen CR, Pilarowski GO, Wang W, et al.Molecular characterisation of the Hyp deletion and an improved assay for its detection[J].Bone, 2012, 50(3):592-595.
[5] Farrow EG, Yu X, Summers LJ, et al.Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice[J].Proc Natl Acad Sci USA, 2011, 108(46):E1146-1155.
[6] Seton M, Juppner H.Autosomal dominant hypophosphatemic rickets in an 85 year old woman:characterization of her disease from infancy through adulthood[J].Bone, 2013, 52(2):640-643.
[7] Myakala K, Motta S, Murer H, et al.Renal-specific and inducible depletion of NaPi-IIc/Slc34a3, the cotransporter mutated in HHRH, does not affect phosphate or calcium homeostasis in mice[J].Am J Physiol Renal Physiol, 2014, 306(8):F833-843.
[8] Turan S, Aydin C, Bereket A, et al.Identification of a novel dentin matrix protein-1 (DMP-1) mutation and dental anomalies in a kindred with autosomal recessive hypophosphatemia[J].Bone, 2010, 46(2):402-409.
[9] Levy-Litan V, Hershkovitz E, Avizov L, et al.Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene[J].Am J Hum Genet, 2010, 86(2):273-278.
[10] Rafaelsen SH, Raeder H, Fagerheim AK, et al.Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification[J].J Bone Miner Res, 2013, 28(6):1378-1385.
[11] Chong WH, Molinolo AA, Chen CC, et al.Tumor-induced osteomalacia[J].Endocr Relat Cancer, 2011, 18(3):53-77.
[12] Bowden SA, Patel HP, Beebe A, et al.Successful medical therapy for hypophosphatemic rickets due to mitochondrial complex I deficiency induced de toni-debre-fanconi syndrome[J].Case Rep Pediatr, 2013, 2013(1):1-5.
[13] Quinlan C, Guegan K, Offiah A, et al.Growth in PHEX-associated X-linked hypophosphatemic rickets:the importance of early treatment[J].Pediatr Nephrol, 2012, 27(4):581-588.
[14] Carpenter TO, Imel EA, Holm IA, et al.A clinician's guide to X-linked hypophosphatemia[J].J Bone Miner Res, 2011, 26(7):1381-1388.
[15] Areses-Trapote R, Lopez-Garcia JA, Ubetagoyena-Arrieta M, et al.Hereditary hypophosphatemic rickets with hypercalciuria:case report[J].Nefrologia, 2012, 32(4):529-534.
[16] Zivicnjak M, Schnabel D, Staude H, et al.Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets:effects on linear growth and body disproportion[J].J Clin Endocrinol Metab, 2011, 96(12):E2097-2105.
[17] Pantel G, Probst R, Podvinec M, et al.Hearing loss and fluctuating hearing levels in X-linked hypophosphataemic osteomalacia[J].J Laryngol Otol, 2009, 123(1):136-140.
[18] Douyere D, Joseph C, Gaucher C, et al.Familial hypophosphatemic vitamin D-resistant rickets-prevention of spontaneous dental abscesses on primary teeth:a case report[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 107(4):525-530.
[19] Shimada T.Updates on rickets and osteomalacia:anti-FGF23 antibody, a new therapeutic approach for hypophosphatemic rickets/osteomalacia[J].Clin Calcium, 2013, 23(10):1469-1475.
[20] Fukumoto S.Anti-fibroblast growth factor 23 antibody therapy[J].Curr Opin Nephrol Hypertens, 2014, 23(4):346-351. |
